Finally, upregulated MET expression at both the mRNA and protein level was also reported as a potential inducer of resistance to the FGFR1-3 inhibitor CPL304110 in a FGFR1-amplified NSCLC cell line subjected to chronic exposure to this compound [114]. Here, FGFR1 is linked to non-small cell lung carcinoma.